Elevated expression of AXL also reduces tumor sensitivity to both chemotherapy and poly ADP ribose polymerase (PARP) inhibition [59,68,69], and confers resistance to cisplatin in melanoma cells [60] and in ovarian cancer cells [70]. This evidence concerns the gene AXL and neoplasm.